When a federal judge threw out a $50 million jury award against Merck & Co., calling it excessive for a former FBI agent who had suffered a heart attack while using the drug maker’s Vioxx painkiller, the news was met with mixed feelings for the 16,000 Vioxx users that have filed suits against Merck.
Jury blames Vioxx for man's heart attack, awards $20 million
A New Jersey jury has ruled that Merck painkiller Vioxx contributed to the heart attack of a postal worker.
TORONTO | Following deliberations about the safety of COX-2 inhibitors for the treatment of musculoskeletal disorders, an expert advisory panel has told Health Canada that Vioxx should be allowed back on the market following its voluntary removal by Merck last year due to concerns that the drug increases the risk of cardiovascular disease risk.
Forgotten victims of Vioxx still fighting for justice
A woman prescribed a controversial drug for arthritis which was withdrawn amid serious health fears believes she could be among hundreds of “forgotten patients” from Northern Ireland still fighting for compensation.
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved